Cargando…
End of induction MRD assessment based early treatment intensification with novel agents in ETP-ALL-may be the way forward
Autores principales: | Patra, Pritish Chandra, Rainchwar, Sujay, Singh, Reema, Halder, Rohan, Mehta, Pallavi, Verma, Megha, Ahmed, Rayaz, Raichaudhuri, Jyoti Shankar, Bhurani, Dinesh, Agrawal, Narendra, Pramanik, Suman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310492/ https://www.ncbi.nlm.nih.gov/pubmed/37160382 http://dx.doi.org/10.5045/br.2023.2022241 |
Ejemplares similares
-
Hemophagocytic Lymphohistiocytosis (HLH): A Rare Cause of Primary Engraftment Failure Post Autologous Stem Cell Transplant
por: Mehta, Pallavi, et al.
Publicado: (2023) -
A Retrospective Cohort Study of Upfront Nilotinib in Chronic Myeloid Leukemia: A Single-Center Experience
por: Singh, Reema, et al.
Publicado: (2021) -
Retrospective Study of Carfilzomib-Pomalidomide-Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients in a Tertiary Care Hospital in India
por: Mehta, Pallavi, et al.
Publicado: (2021) -
Origins of ETP leukemia
por: Booth, Christopher A. G., et al.
Publicado: (2018) -
On the Origin of ETP Leukemias
por: Tesio, Melania
Publicado: (2018)